These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9126810)

  • 1. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
    Kruger M; Böker KH; Zeidler H; Manns MP
    J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
    Sangfelt P; Uhnoo I; Hollander A; Lindh G; Weiland O
    Scand J Infect Dis; 2002; 34(7):505-11. PubMed ID: 12195876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.
    Erhardt A; Sagir A; Guillevin L; Neuen-Jacob E; Häussinger D
    J Hepatol; 2000 Oct; 33(4):677-83. PubMed ID: 11059878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined interferon, famciclovir and GM-CSF treatment of HBV infection in an individual with periarteritis nodosa.
    Molloy PJ; Friedlander L; Van Thiel DH; Kania RJ
    Hepatogastroenterology; 1999; 46(28):2529-31. PubMed ID: 10522033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
    Manns MP; Neuhaus P; Atkinson GF; Griffin KE; Barnass S; Vollmar J; Yeang Y; Young CL;
    Transpl Infect Dis; 2001 Mar; 3(1):16-23. PubMed ID: 11429035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir in chronic hepatitis B: results of a dose-finding study.
    Trépo C; Jezek P; Atkinson G; Boon R; Young C
    J Hepatol; 2000 Jun; 32(6):1011-8. PubMed ID: 10898322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
    Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
    Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B.
    Pichoud C; Berby F; Stuyver L; Petit MA; Trépo C; Zoulim F
    J Hepatol; 2000 Feb; 32(2):307-16. PubMed ID: 10707872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
    Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B.
    Marques AR; Lau DT; McKenzie R; Straus SE; Hoofnagle JH
    J Infect Dis; 1998 Nov; 178(5):1483-7. PubMed ID: 9780271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
    Lackner H; Moser A; Benesch M; Deutsch J; Kessler HH; Kerbl R; Schwinger W; Dornbusch HJ; Sovinz P; Urban C
    J Clin Virol; 2002 Dec; 25 Suppl 3():S73-9. PubMed ID: 12467780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical investigation of famciclovir in chronic hepatitis B patients irresponsive to alpha interferon treatment].
    Wang ZY; Guo SH; Zhang DF; Zhao YR; Ren H; Zhou XQ; Xu DZ; Sun JY; Yao JL; Lu WL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):494-6. PubMed ID: 16042882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
    Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
    Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians.
    Guptan RC; Thakur V; Malhotra V; Sarin SK
    J Gastroenterol Hepatol; 1998 Jul; 13(7):675-9. PubMed ID: 9715416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
    Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
    Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
    Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
    Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
    J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in antiviral therapy for chronic hepatitis B infection.
    De Man RA; Heijtink RA; Niesters HG; Schalm SW
    Scand J Gastroenterol Suppl; 1995; 212():100-4. PubMed ID: 8578221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
    Lau GK; Liang R; Wu PC; Lee CK; Lim WL; Au WY
    J Hepatol; 1998 Mar; 28(3):359-68. PubMed ID: 9551671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.